← FDA Drug Approvals (Drugs@FDA)

VELETRI

NDA · New Drug Application · Sponsor: ACTELION · Approved 2008-06-27

Drug application

FDA Application #

NDA022260

Application type

New Drug Application

Brand name

VELETRI

Generic name

EPOPROSTENOL

Active ingredients

EPOPROSTENOL SODIUM

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

ACTELION

Manufacturer

Actelion Pharmaceuticals US, Inc.

First approval

2008-06-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown